Target · Near-term · 1+2 — Other
2022 → 2030 · 1.5°C · published 2025-01-09
Envision Pharma Group Ltd commits to reduce absolute scope 1 and 2 GHG emissions 55% by 2030 from a 2022 base year.
The standards
Does it apply to you
Reporting under it
Start here
Dates and penalties
Doing it
What you must file
Doing it
Start here
Setting targets
Who and where
The UK duty
Doing it
The baseline
Europe
Reporting more widely
Carbon markets and trade
Packaging and net zero
Carbon accounting
Choosing
Carbon
Compliance and offsets
Software
Templates
Careers
SBTi company profile · UK
Professional Services Corporate
Validated Targets
Data: Science Based Targets initiative Target Dashboard, as at 2026-10-08
Published records
The records below are reproduced from the Science Based Targets initiative Target Dashboard. A validated target is not evidence that emissions have fallen; progress requires the company’s reported emissions.
Target · Near-term · 1+2 — Other
2022 → 2030 · 1.5°C · published 2025-01-09
Envision Pharma Group Ltd commits to reduce absolute scope 1 and 2 GHG emissions 55% by 2030 from a 2022 base year.
Target · Near-term · 3 — Other
2023 → 2030 · published 2025-01-09
Envision Pharma Group Ltd also commits to reduce scope 3 GHG emissions from business travel 52% per FTE by 2030 from a 2023 base year.
Target · Near-term · 3 — Other
2023 → 2028 · published 2025-01-09
Envision Pharma Group Ltd further commits that 75% of its suppliers by emissions covering purchased goods and services and upstream transportation and distribution will have science-based targets by 2028.
Commitment — Validated Targets